Adjuvant treatment in high-risk breast cancer

被引：0
|
作者：
Mansi, JL
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 1996年 / 56卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [1] Abemaciclib as adjuvant treatment for high-risk early breast cancer
    Andrades, Ana Ganfornina
    Caballero, Silvia Fenix
    Olid, Alba Salguero
    Emilio, Jesus Alegre Del-Rey
    FARMACIA HOSPITALARIA, 2024, 48 (02) : 75 - 78
  • [2] Adjuvant chemotherapy for high-risk operable breast cancer
    Buzdar, Aman U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1642 - 1644
  • [3] DOSE-INTENSE ADJUVANT TREATMENT OF HIGH-RISK BREAST-CANCER
    BONADONNA, G
    VALAGUSSA, P
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (07) : 542 - 543
  • [4] Adjuvant treatment in high risk breast cancer
    Jones, A
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1996, 55 (04): : 156 - 158
  • [5] High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients
    Bertuzzi, A
    Gullo, G
    Rimassa, L
    Castagna, L
    Santoro, A
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 719 - 720
  • [6] Neoadjuvant and adjuvant treatment in high-risk prostate cancer
    Bandini, Marco
    Fossati, Nicola
    Gandaglia, Giorgio
    Preisser, Felix
    Dell'Oglio, Paolo
    Zaffuto, Emanuele
    Stabile, Armando
    Gallina, Andrea
    Suardi, Nazareno
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    Briganti, Alberto
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 425 - 438
  • [7] Abemaciclib combined with endocrine therapy for the adjuvant treatment of high-risk early breast cancer
    Johnston, Stephen R. D.
    Harbeck, Nadia
    Hegg, Roberto
    Toi, Mazakazu
    Martin, Miguel
    Shao, Zhimin
    Campone, Mario
    Hamilton, Erika
    Sohn, Joohyuk
    Guarneri, Valentina
    Cortes, Javier
    Neven, Patrick
    Boyle, Frances
    Smith, Ian C.
    Frenzel, Martin
    Headley, Desiree
    Wei, Ran
    Cox, Joanne
    O'Shaughnessy, Joyce
    Rastogi, Priya
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 112 - 113
  • [8] Adjuvant abemaciclib for high-risk breast cancer: the story continues
    Spring, L.
    Matikas, A.
    Bardia, A.
    Foukakis, T.
    ANNALS OF ONCOLOGY, 2021, 32 (12) : 1457 - 1459
  • [9] SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDCT) AND IMMUNOTHERAPY IN THE ADJUVANT TREATMENT OF HIGH-RISK BREAST CANCER
    Recchia, F.
    Saggio, G.
    Cesta, A.
    Rea, S.
    ANNALS OF ONCOLOGY, 2004, 15 : 21 - 22
  • [10] Prediction of responsiveness to adjuvant anthracyclines in high-risk breast cancer patients
    Brunner, N.
    Ejlertsen, B.
    Jensen, M.
    Nielsen, K. V.
    Balslev, E.
    Rasmussen, B. B.
    Willemoe, G. L.
    Hertel, P. B.
    Knoop, A.
    Mouridsen, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345